85 FR 47 pg. 13928 - Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research
Type: NOTICEVolume: 85Number: 47Page: 13928
Page: 13928Docket number: [Docket No. DEA-579]
FR document: [FR Doc. 2020-04831 Filed 3-9-20; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-579]
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 11, 2020.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on December 13, 2019, Sigma Aldrich Research, Biochemicals, Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances:
| Controlled substance | Drug code | Schedule |
|---|---|---|
| Cathinone | 1235 | I |
| Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I |
| Lysergic acid diethylamide | 7315 | I |
| Tetrahydrocannabinols | 7370 | I |
| 3,4-Methylenedioxymethamphetamine | 7405 | I |
| Alpha-methyltryptamine | 7432 | I |
| Dimethyltryptamine | 7435 | I |
| 5-Methoxy-N,N-diisopropyltryptamine | 7439 | I |
| N-Benzylpiperazine | 7493 | I |
| 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) | 7517 | I |
| MDPV (3,4-Methylenedioxypyrovalerone) | 7535 | I |
| Methylone (3,4-Methylenedioxy-N-methylcathinone) | 7540 | I |
| Heroin | 9200 | I |
| Normorphine | 9313 | I |
| Norlevorphanol | 9634 | I |
| Amphetamine | 1100 | II |
| Nabilone | 7379 | II |
| Phencyclidine | 7471 | II |
| Cocaine | 9041 | II |
| Codeine | 9050 | II |
| Ecgonine | 9180 | II |
| Levorphanol | 9220 | II |
| Meperidine | 9230 | II |
| Methadone | 9250 | II |
| Morphine | 9300 | II |
| Thebaine | 9333 | II |
| Levo-alphacetylmethadol | 9648 | II |
| Noroxymorphone | 9668 | II |
| Remifentanil | 9739 | II |
| Sufentanil | 9740 | II |
| Carfentanil | 9743 | II |
| Fentanyl | 9801 | II |
The company plans to manufacture small quantities of the listed controlled substances to make reference standards for distribution to its customers.
Dated: February 10, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-04831 Filed 3-9-20; 8:45 am]
BILLING CODE 4410-09-P